TROPISETRON (NAVOBAN(R)) COMPARED WITH ALIZAPRIDE IN THE CONTROL OF EMESIS INDUCED BY CYCLOPHOSPHAMIDE-CONTAINING REGIMENS

被引:3
作者
DENIGRIS, A [1 ]
PALADINI, G [1 ]
GIOSA, F [1 ]
SFEIR, C [1 ]
PAGAN, MG [1 ]
MALTONI, C [1 ]
机构
[1] SANDOZ PROD FARMACEUT SPA,MILAN,ITALY
关键词
D O I
10.1016/0959-8049(94)00241-V
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1902 / 1903
页数:2
相关论文
共 9 条
[1]   EXTRAPYRAMIDAL REACTIONS WITH METOCLOPRAMIDE [J].
BATEMAN, DN ;
RAWLINS, MD ;
SIMPSON, JM .
BRITISH MEDICAL JOURNAL, 1985, 291 (6500) :930-932
[2]   ANTIEMETIC ACTION OF 5-HT-3 RECEPTOR ANTAGONISTS - REVIEW OF PRECLINICAL AND CLINICAL-RESULTS WITH ICS 205-930 [J].
GAMSE, R .
CANCER TREATMENT REVIEWS, 1990, 17 (2-3) :301-305
[3]   THE ANTIEMETIC ACTIVITY OF HIGH-DOSE ALIZAPRIDE AND HIGH-DOSE METOCLOPRAMIDE IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL [J].
JOSS, RA ;
GALEAZZI, RL ;
BISCHOFF, AK ;
PIROVINO, M ;
RYSSEL, HJ ;
BRUNNER, KW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (06) :619-624
[4]   GRANISETRON - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE AS AN ANTIEMETIC [J].
PLOSKER, GL ;
GOA, KL .
DRUGS, 1991, 42 (05) :805-824
[5]  
SCHMOLL HJ, 1989, EUR J CANCER CLIN ON, V25, P535
[6]  
SHERIDAN C, 1982, NEW ENGL J MED, V307, P1346
[7]  
SMITH IE, 1990, EUR J CANCER S1, V26, P519
[8]  
TAGNON HJ, 1989, EUR J CANCER CLIN S1, V25
[9]  
1992, DRUGS S3, V43, P1